Cerebrovascular Disease Associated with Marijuana Abuse: A Case Report

Cerebrovascular disease is one of the overlooked complications of cannabis use. In young patients presenting with symptoms of ischemic stroke, the recent use of cannabinoids should be systematically investigated. Yet, cannabis use is widespread and some countries have taken further steps to legalize it. Here we present the case of a 29-year-old patient who had two several ischemic strokes within two months, each time after an important cannabis ingestion. This case illustrates the role cannabis can play in ischemic strokes occurring in young patients even though the pathophysiology of such an implication is not totally elucidated.

Download Full-text

Sneddon’s Syndrome: a case report

10.5327/1516-3180.159 ◽

2021 ◽

Author(s):

Letícia Alves de Sousa ◽

Luís Marcos Ferreira Junior ◽

Lolrrayna Pedroso de Lima ◽

Priscilla Rezende Pereira Silva ◽

Marcus Vinícius de Araújo Vieira

Keyword(s):

Case Report ◽

Cerebrovascular Disease ◽

Secondary Prophylaxis ◽

Livedo Reticularis ◽

Acute Ischemia ◽

Left Hemiparesis ◽

Sneddon's Syndrome ◽

Sneddon’S Syndrome ◽

Positive Antibody ◽

Aetiological Diagnosis

Context: Sneddon’s Syndrome is a small and medium caliber arteries vasculopathy, characterized by concomitant occurrence of cerebrovascular disease and livedo reticularis. It’s a rare disorder, more prevalent in women. In up to 80% of cases, positive antiphospholipid’s antibodies are found. Case report: A 28-year-old woman was admitted to Hospital das ClínicasUFTM on May 21th, 2020, referred under suspicion of stroke with ictus on May 19th, 2020. The exam revealed left hemiparesis, anomic afasia and livedo reticularis on her thighs and thorax. She denied having comorbidities or previous episodes of thromboembolism. She had taken combined oral contraceptive for eleven years, having changed medication a year ago. In the cranial angioresonance exam, acute ischemia was confirmed in addition to moderate microangiopathy and an area of encephalomalacia. In the etiological investigation, HEP-2 positive antibody (antinuclear factor in a fine dotted nuclear pattern) was detected. She was discharged with a prescription of 100 mg of acetylsalicylic acid daily, maintained as a form of secondary prophylaxis. Conclusions: The case illustrates the importance of a thorough physical examination and anamnesis in cerebrovascular disease patients, in order to get a accurate aetiological diagnosis of these diseases, enabling a more effective prognostic evaluation and secondary prophylaxis.

Download Full-text

Clinical Features of COVID‐19 in a Young Man with Massive Cerebral Hemorrhage: Case Report

10.21203/rs.3.rs-26232/v1 ◽

2020 ◽

Cited By ~ 2

Author(s):

Yi Bao ◽

Shu Yu Lin ◽

Zhao Hui Cheng ◽

Jun Xia ◽

Yan Peng Sun ◽

...

Keyword(s):

Cerebrospinal Fluid ◽

Case Report ◽

Cerebrovascular Disease ◽

Clinical Features ◽

Critically Ill Patients ◽

Cerebral Hemorrhage ◽

High Morbidity ◽

Cerebral Blood Vessels ◽

Multiple Systems ◽

The World

Abstract COVID-19 is currently a pandemic in the world, can invade multiple systems, and has a high morbidity and mortality. So far, no cases of acute cerebrovascular disease have been reported. This article reports the clinical features of a COVID-19 patient whose first symptom was cerebral hemorrhage. More importantly, after the craniotomy, the patient had high fever and it was difficult to retreat. After cerebrospinal fluid testing, it was determined that an intracranial infection had occurred. After anti-infection and plasma infusion of the recovered person, the patient's symptoms gradually improved. This case suggests that COVID-19 may infringe on cerebral blood vessels and cause cerebral hemorrhage. Transfusion of plasma from rehabilitation patients is effective for critically ill patients.

Download Full-text